Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT05670028
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT05670028
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT05670028. Randomized; no masking; primary purpose treatment. Start 2023-06-04 (anticipated); primary completion 2026-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization
- Acronym
- RESCUE-CA
- Condition
- Ischemic Stroke
- Condition
- Revascularization
- Condition
- Blood Pressure
- Condition
- Cerebrovascular Insufficiency
- Condition
- Cerebral Autoregulation
- Condition
- Individuation
- Condition
- Hemorrhagic Transformation Due to Acute Stroke
- Intervention (Drug)
- Hypotensive Drugs and/or Vasoactive Drugs
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct05670028- Content hash
d943623c5f1d480d2f5752fc1448357b1aa31bde19e563ff6068e5bde8957a52